Initial Statement of Beneficial Ownership (3)
May 10 2021 - 06:03PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Bunting Daniel |
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/30/2021
|
3. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [AHCO]
|
(Last)
(First)
(Middle)
C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) COO - Branch Operations / |
(Street)
PLYMOUTH MEETING,, PA 19462
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Class A Common Stock | 58719 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Employee Stock Option (right to buy) | 2/2/2021 (1) | 1/1/2023 | Class A Common Stock | 223628 | $2.69 | D | |
Employee Stock Option (right to buy) | 2/2/2021 (1) | 8/1/2026 | Class A Common Stock | 89451 | $4.38 | D | |
Employee Stock Option (right to buy) | 2/2/2021 (1) | 3/1/2030 | Class A Common Stock | 180021 | $8.50 | D | |
Explanation of Responses: |
(1) | Options are fully vested. |
Remarks: Exhibit 24 - Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Bunting Daniel C/O ADAPTHEALTH LLC 220 WEST GERMANTOWN PIKE, SUITE 250 PLYMOUTH MEETING,, PA 19462 |
|
| COO - Branch Operations |
|
Signatures
|
/s/ Christopher Joyce, as attorney-in-fact for Daniel Bunting | | 5/10/2021 |
**Signature of Reporting Person | Date |
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Feb 2024 to Mar 2024
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Mar 2023 to Mar 2024